Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.

Also called NCT06453876

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06453876
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06453876. Randomized; no masking; primary purpose treatment. Start 2026-06-17 (actual); primary completion 2028-06-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)
Acronym
STRATIFY-II
Intervention (Device)
Ultrasound assisted Thrombolysis
Intervention (Device)
Percutaneous Embolectomy
Intervention (Drug)
Heparin
Lead sponsor
Jesper Kjaergaard (class: other)
Collaborator
Zealand University Hospital (class: other)
Collaborator
Copenhagen University Hospital at Herlev (class: other)
Collaborator
Odense University Hospital (class: other)
Collaborator
Aalborg University Hospital (class: other)

Record details

Record id
cardio:ct-nct06453876
Content hash
1bc2fe52b35dfbfc7ece1273c0f0272d218137b3cb6d69f0a69d2d59f89a137f